Park Medi World Ltd

Q1 FY26 Earnings Call Analysis

Healthcare Services

Full Stock Analysis
fundraise: Nocapex: Yesrevenue: Category 2margin: Category 3orderbook: Yes
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- The company currently has approximately 1,500 beds under execution. - These new capacity additions are expected to be operational by March 2028. - This expansion will increase total bed capacity to 5,460 by that time. - Total planned capex for the next two years is around INR 500 crores. - Recent investments include Panchkula Greenfield construction, and acquisitions/commissioning of Bathinda, Agra, and Narela hospitals. - The company is aggressively looking for further expansion opportunities and is open to acquisitions or Greenfield projects, focusing on strategic, low-capex growth. - Funding is primarily from existing cash reserves and operational cash flow; small debt may be considered but is not a major reliance.
💰

fundraise

Any current/future new fundraising through debt or equity?

- The company currently has sufficient funds, including close to INR314 crores in fixed deposits and about INR100 crores in bank accounts. - Operating cash flow is strong (close to INR330 crores annually), supporting internal funding capabilities. - For the near term, minor debt may be considered but no major debt raising is planned. - The company emphasizes maintaining low capex and financial discipline to avoid heavy borrowing. - For large acquisitions or expansion opportunities, the company is open to raising debt if found lucrative. - No explicit mention of planned equity fundraising was made in the provided excerpts. - Overall, expansion and acquisitions are expected to be funded primarily through internal accruals and existing cash reserves, with selective, small debt as needed.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- Park Medi World is undertaking a significant bed expansion with a capex of about INR 34 lakhs per bed, aiming to increase capacity to 5,460 beds by FY’28 and potentially doubling to over 10,000 beds by FY’33. - Current capex underway includes: - Panchkula: 350 beds with INR 125 crores invested. - Delhi Narela: 200 beds with total planned capex INR 80 crores (INR 55 crores spent). - Kanpur: Additional INR 30 crores planned. - Capex planned for FY’27 is about INR 55 crores; for FY’28, approximately INR 250 crores. - Future capex of close to INR 500 crores projected for next two years, funded primarily through internal accruals and cash reserves, with minor debt if needed. - Strategic investments focus on nearby hospitals (within 40-50 km) to create operational synergies, keeping capex and opex controlled.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- Park Medi World plans significant bed expansion: adding 1,850 beds currently under execution, with 350 beds added at Panchkula and 200 beds at Delhi Narela. - Capex guidance: INR55 crores planned for the current year and approximately INR250 crores in FY28 for adding 1,000 beds. - Long-term vision (FY28 to FY33): Plans to double bed capacity from 5,460 to over 10,000 beds. - Expansion focus on Tier-2 and Tier-3 cities due to growing demand for affordable, high-quality healthcare, reducing patient outflow to metros. - Continued increase in government insurance payor mix expected to stabilize around 70%. - Revenue growth drivers include case mix improvement towards higher acuity specialties and operational efficiencies. - No major debt funding planned; capex funded from internal resources to ensure sustainable growth.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- The company plans significant bed capacity expansion, aiming to increase beds from 5,460 in FY’28 to over 10,000 by FY’33, potentially doubling capacity. - Capex for FY’28 is expected around INR 250 crores, focused on adding 1,000 beds; no major new debt anticipated. - Revenue growth is supported by expanding into Tier-2 and Tier-3 cities, meeting strong demand for affordable, high-quality healthcare. - ARPOB (average revenue per occupied bed) growth is expected around 5-6%, driven by improved case mix and high-end procedures. - Operating efficiencies and low capex per bed (~INR 34 lakhs) help maintain profitability despite inflationary pressures. - Government insurance mix (~70%) remains stable, supporting steady collections and reduced receivable days (currently 129 days). - Overall, the company anticipates sustainable long-term profitability growth through strategic expansions and operational excellence.